The United States Federal Trade Commission (FTC) filed an administrative complaint against the nation’s three largest prescription drug benefit managers (PBMs) – Caremark Rx, Express Scripts (ESI), and OptumRx – and their affiliated group purchasing organizations (GPOs) for engaging in alleged anticompetitive and unfair rebating practices. The FTC…